FOLH1 and hepatocellular carcinoma: Other groups also applied a dual-tracer PET approach to HCC patients, reporting similar findings and suggesting that the use of PSMA-based imaging could offer a valuable tool in T and N staging in addition to MRI, opening new perspectives for planning a PRLT [32,33].